| Name | EPAC 5376753 |
|---|
| Description | EPAC 5376753 is an allosterically inhibitor of Epac which inhibits Epac1 with an IC50 of 4 µM in Swiss 3T3 cells. |
|---|---|
| Related Catalog | |
| Target |
IC50: 4 µM (Epac)[1] |
| In Vitro | Epac is a key mediator of cAMP signaling. EPAC 5376753, the thiobarbituric acid modification of 5225554, has a greater ability to decrease the conformational changes of Epac necessary for its activation and to inhibit Epac signaling in cells. 5376753 selectively inhibits Epac-mediated migration in fibroblasts[1]. |
| Cell Assay | Swiss 3T3 cells are treated with EPAC 5376753 (1, 10, 25, 50, 75, 100 μM) or 1% dimethyl sulfoxide for 48 h. Cell viability is assessed using the CellTiter-Glo assay[1]. |
| References |
| Molecular Formula | C15H8Cl2N2O3S |
|---|---|
| Molecular Weight | 367.21 |
| Hazard Codes | Xi |
|---|